BeOne Medicines

02/04/2026

This , we did something difficult.

We tried to describe cancer in just one word.

Even though cancer is complex. And personal. And sometimes isolating.

In the spirit of being united by our unique experiences, we made our word HOPE.

Hope is what drives us forward. It's what unites us in our mission. It's the foundation of every breakthrough, every treatment, and every life we fight to save.

Now it’s your turn.

Whether you’re a patient, survivor, caregiver, researcher, healthcare professional, or someone who’s lost someone to cancer—your experience matters.

One word can’t capture it all.

But one word can help others feel seen and understood.

What’s YOUR one word?

UICC - Union for International Cancer Control

02/02/2026

More than 40 million people now use ChatGPT daily for health-related questions - and cancer patients are increasingly turning to tools to help make sense of their diagnosis, lab results, and treatment options.

In collaboration with Katie Couric Media, this article outlines practical guidance to help patients and caregivers understand when AI tools can be helpful, when to turn to their doctor or an advocacy organization, and how to navigate cancer care with greater confidence.

Swipe to learn more, and read the full article here: https://katiecouric.com/health/cancer/chatgpt-medical-advice-for-cancer/

01/28/2026

As more patients turn to AI for answers, it’s critical that these tools support, not replace, conversations with clinicians and advocates. We’re proud to partner with Katie Couric to help patients responsibly harness AI tools, so they can navigate cancer care with clarity and confidence.

A practical guide to using AI tools without falling into misinformation or anxiety spirals.

01/27/2026

At BeOne, we know cancer is too complex to solve alone and we’re stronger together.

To kick off season two of the Cancer Has No Borders podcast, our SVP and Chief Medical Officer, Solid Tumors, Mark Lanasa, joins to talk about the value of partnerships with patients to better understand the cancer journey, and close gaps in education, diagnosis, and access.

Watch the full episode here: https://youtu.be/xq8Q2VdzUG8?si=GmGAuRntuTAejPrt

Or listen on your favorite platform:
Apple: https://podcasts.apple.com/us/podcast/episode-13-inside-beones-global-oncology-pipeline-with/id1784166790?i=1000746869490
Spotify: https://open.spotify.com/episode/4YVTCmlJ7d4eHwsfc5oIX7?si=p09tNhCNRbWvaSx8soJKnQ
Amazon: https://www.amazon.com/Cancer-Has-No-Borders/dp/B0DPW4WSN3

01/26/2026

01/23/2026

BeOne is proud to support today’s Cancer Support Community South Bay roundtable - bringing patients, caregivers, and providers together to raise awareness of insurance access barriers and keep cancer treatment decisions where they belong: between patients and their doctors.

The hidden burdens of cancer go beyond treatment.

Insurance delays and denials can stand between patients and the care they need.

Join us for a FREE panel discussion + community roundtable focused on putting patients over paperwork and protecting access to prescribed care.

🗓 Friday, January 23, 2026
📍 FREE IN-PERSON & ONLINE
🍽️ Lunch 12:30–1pm
🕐 Panel 1–2pm PST
📌 CSC South Bay + Zoom

Hear from patients, caregivers, and providers.
Share your story. Ask questions. Be part of the conversation.

✨ Lunch, raffle, and a small gift for in-person attendees
👉 Register at www.CSCSouthBay.org

01/22/2026

As part of our commitment to improving access to cancer care around the world, we’re pleased to announce that the BeOne Care Foundation has shared a grant with Federatia Asociatiilor Bolnavilor de Cancer din Romania.

This funding will provide free oncological testing in rural areas of Romania, delivering medical consultations and blood tests to people facing barriers to accessing care.

It’s one example of how we continually support partner organizations and make a real difference to patient communities across the globe. By working together, we can create meaningful change so that access to cancer care is not defined by geography.

01/16/2026

As we look ahead to 2026, our commitment remains unwavering – standing up for patients, everywhere.

From day one, we’ve set out to defy the status quo, reimagining how life-changing cancer therapies are discovered, developed, and delivered to those who need them most.

For us, access isn’t an aspiration – it’s an imperative. With ~2 million patients worldwide already treated with our medicines, we know this is just the beginning.

01/10/2026

As ASCO comes to a close, we’re reflecting on an inspiring few days of collaboration and forward momentum in GI oncology.

One of the clear highlights of the meeting was the presentation of positive Phase 3 results in patients with HER2+ GEA. The strong interest and discussion around these data underscore the potential impact in upper .

A huge thank you to the researchers, clinicians, partners, and advocates who contributed to the valuable dialogue throughout the Symposium.

We’re looking forward to what comes next!

01/09/2026

Gastroesophageal adenocarcinoma, or GEA, is a type of cancer that includes cancers of the stomach, gastroesophageal junction, and esophagus.

At this year’s ASCO Symposium, is highlighting important Phase 3 data in GEA.

Our Head of Global Medical Affairs for Solid Tumors, Nadeem Ghali, shares his take on this data from the congress floor.

12/24/2025

From all of us at , we wish you a joyful, peaceful holiday season!

Enjoy a restful break with your loved ones, and we’ll see you in 2026!

12/22/2025

As 2025 comes to a close, we’re taking a moment to look back and celebrate the progress we’ve made in the last 12 months.

It’s been an amazing year of insights, breakthroughs, and innovations. Thank you to everyone who has been part of the journey of our shared mission! Bring on 2026!